D-dimer levels remain elevated in acute aortic dissection after 24 h

J Surg Res. 2014 Sep;191(1):58-63. doi: 10.1016/j.jss.2014.03.074. Epub 2014 Apr 1.

Abstract

Background: D-dimer levels are elevated in patients with acute aortic dissection (AAD). Although D-dimer levels have been used to rule out AAD within 24 h of symptom onset, it is unknown whether they may be used reliably after 24 h but within the acute period. Here, we tested the hypothesis that D-dimer levels remain elevated in AAD patients for at least 10 d after dissection onset.

Materials and methods: D-dimer levels were measured in preoperative heparinized plasma samples from 100 patients with confirmed AAD for up to 10 d after onset of dissection. When possible, serial samples were obtained for ≥2 d. D-dimer levels were measured in fibrinogen equivalent units using a BCS XP automated coagulation analyzer, which is approved for citrated samples. Therefore, we first validated our samples by comparing D-dimer levels in heparinized and citrated plasma samples from 29 individuals, including patients with and without aortic disease and healthy donors.

Results: The correlation between heparinized and citrated plasma samples was 0.991 (P ≤ 0.001). At a threshold of 1.6 μg/mL, the overall sensitivity of the D-dimer assay in AAD patients up to 10 d after onset of dissection was 95.3%.

Conclusions: D-dimer levels remained elevated in AAD patients over a 10-d period after dissection onset and may be helpful in ruling out AAD in patients who seek treatment after the first 24 h but within the acute period. Heparinized plasma samples may be substituted for citrated samples when evaluating D-dimer levels using the BCS XP coagulation analyzer.

Keywords: Aortic dissection; D-dimer; Diagnosis; Marker; Sensitivity.

Publication types

  • Research Support, N.I.H., Extramural
  • Validation Study

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Anticoagulants
  • Aortic Aneurysm / blood*
  • Aortic Dissection / blood*
  • Biomarkers / blood
  • Blood Specimen Collection / methods
  • Blood Specimen Collection / standards
  • Chemistry, Clinical / methods*
  • Chemistry, Clinical / standards*
  • Citric Acid
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Heparin
  • Humans
  • Hypertension / blood
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Time Factors

Substances

  • Anticoagulants
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Citric Acid
  • Heparin